Clinical trial
Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction…
NCT00256399 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00256399 |
|---|---|
| Title | Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED) |
| Official title | A Prospective, Open Label, Study to Assess the Efficacy of Alfuzosin 10 mg Tablet Once a Day in Male Subjects Suffering From Benign Prostate Hypertrophy Associated Lower Urinary Tract Symptoms and Erectile Dysfunction |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | BPH, Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | Alfuzosin 10 mg |
| Enrollment | 6 |
| Start date | Nov 1, 2005 |
| Primary completion | May 8, 2007 |
| Completion | May 8, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Aug 15, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: